甲状腺激素干预H-ras12V转基因肝癌小鼠对肝肿瘤的影响研究

doi:10.3969/j.issn.1672-5069.2018.01.030

Abstract

Bai Yun, Gong Fangming, Tian xingsong. Impact of serum thyroid hormone levels on H-ras12V transgenic mice with liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 116-117.

[1] 罗翠松,汪珍光,林云,等. 年龄对肝癌合并糖尿病患者预后的影响：基于倾向值匹配的分析. 第二军医大学学报,2016,37（9）：1171-1175.
[2] 张秀云. 高龄人群血清促甲状腺激素、血脂水平与年龄的相关性分析. 临床心血管病杂志,2016,32（4）：421-423.
[3] Memon NS,Kazi TG,Afridi HI,et al. Correlation of manganese with thyroid function in females having hypo-and hyperthyroid disorders. Biol Trace Elem Res,2015,167（2）:165-171.
[4] Ajavon A,Killian D,Odom R,et al. Influence of thyroid hormone disruption on the incidence of shingles. Epidemiol Infect,2015,143（16）:3557-3571.
[5] 杨榕,范晨玲,毕美,等. 自身免疫性甲状腺炎小鼠发病中调节性T细胞、Th17细胞的变化. 实用药物与临床,2014,17（12）：1511-1515.
[6] 赵宏,刘海彤,魏冰,等. 甲状腺功能亢进合并肝损害30例临床特点及其治疗效果. 中国伤残医学,2015,23（9）：117-118.
[7] 冼中任,方伟祯,黄坚,等. Graves甲状腺功能亢进性心脏病患者肝功能异常的临床分析. 广东医学,2015,36（21）：3342-3344.
[8] 潘倩,章建全. 甲状腺腺瘤与肝海绵状血管瘤同期联合微波消融治疗的初步尝试. 第二军医大学学报,2015,36（5）：573-576.
[9] 刁海鑫,吴文溪,邓勇. 甲状腺全切术治疗原发性甲状腺功能亢进疗效及对患者心脏功能和肝功能的影响. 中国现代医学杂志,2014,24（34）：94-97.
[10] 应爱华. 丙硫氧嘧啶与甲巯咪唑对甲状腺功能亢进症肝功能影响情况的对比研究. 中国医药导报,2014,11（4）：71-73.
[11] 赵荣兰,宋伟,孙艳丽,等. 甲状腺激素受体β对大鼠肝癌细胞RH-35凋亡和增殖的影响. 中华内分泌代谢杂志,2016,32（8）：691-695.
[12] 陈强,谢庆吉,岑宏,等. P21激活激酶1在甲状腺乳头状癌中的表达及临床意义的研究.中华普通外科学文献（电子版）,2015,9（5）：21-24.
[13] 谢莲,曾锦章,杨汀,等. TPA诱导肝癌细胞SMMC7721凋亡及与RXRα和TR3的关系.云南大学学报：自然科学版,2006,28（3）：271-276.
[14] 刘辉,杨波,吴亮亮,等. Th/Tr淋巴细胞比值评估乳腺癌患者抗肿瘤免疫状态. 现代肿瘤医学,2010,18（4）：689-691.
[15] 熊玮,骆瑜,董少红,等. 微小RNA-146a上调cyclin D1表达诱导大鼠血管平滑肌细胞的增殖.中国免疫学杂志,2016,32（7）：974-978.
[16] 程静屏,傅念,罗艳云,等. 甲状腺素对非酒精性脂肪肝大鼠ANGPTL3表达的影响. 中南医学科学杂志,2016,44（1）：25-28.
[17] 卢文丽,方肇勤,潘志强,等. 甲状腺激素释放相关水解酶基因在H22肝癌小鼠早期不同证候中的表达特征. 国际中医中药杂志,2014,36（7）：623-627.
[18] 段宏. 抗甲状腺功能亢进症药物致肝功能损害的临床分析. 临床合理用药杂志,2014,7（22）：63-64.
[19] 何珂,胡蕴. 促甲状腺激素受体抗体对人肝癌细胞HepG2凋亡和增殖的影响. 临床荟萃,2014,29（1）：45-48.
[20] 张敏,聂鑫,董建一,等. 甲状腺激素对Ras癌基因诱导的肝肿瘤抑制作用研究. 中华肿瘤防治杂志,2015,22（20）：1596-1601.

Impact of serum thyroid hormone levels on H-ras12V transgenic mice with liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[2]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[3]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[4]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[5]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[6]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[7]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[8]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[9]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[10]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[11]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[12]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[13]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[14]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.
[15]	Chen Xiang, Wang Baolin, Wu Chen, et al.. Efficacy of transcatheter arterial chemoembolization and radion implantation in the treatment of patients with primary liver cancer and its impact on hepatic expressions of TRF1 and TRF2 [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 121-124.